Mavik and Cutivate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 5 people who take Mavik and Cutivate. Common interactions include depression among females.

The phase IV clinical study analyzes what interactions people who take Mavik and Cutivate have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 03, 2023

5 people who take Mavik and Cutivate together, and have interactions are studied.

What is Mavik?

Mavik has active ingredients of trandolapril. It is used in high blood pressure. Currently, eHealthMe is studying from 3,096 Mavik users.

What is Cutivate?

Cutivate has active ingredients of fluticasone propionate. Currently, eHealthMe is studying from 305 Cutivate users.

Number of Mavik and Cutivate reports submitted per year:

Common Mavik and Cutivate drug interactions by gender *:

female:

Depression
Generalised anxiety disorder
Ventricular hypertrophy
Agitation
Anxiety
Emotional distress
Myocardial infarction
Post-traumatic stress disorder
Sleep disorder
Chest pain

male:

n/a

Common Mavik and Cutivate drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Depression
Generalised anxiety disorder
Ventricular hypertrophy
Agitation
Anxiety
Emotional distress
Myocardial infarction
Post-traumatic stress disorder
Sleep disorder
Chest pain

50-59:

n/a

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Mavik and Cutivate?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Lehrer, S., & Rheinstein, P. H. , "Alzheimer’s Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database", Journal of Alzheimer's disease reports, (Preprint), 1-5., 2018 Jan .

Related studies

Drug side effects by duration, gender and age:

Mavik side effects (3,096 reports)
Cutivate side effects (305 reports)

Common Mavik drug interactions:

Mavik and Prednisone: 384 reports
Mavik and Zide: 358 reports
Mavik and Hydrochlorothiazide: 356 reports
Mavik and Aspirin: 339 reports
Mavik and Lipitor: 338 reports
Mavik and Atenolol: 297 reports
Mavik and Metformin: 254 reports
Mavik and Pantoprazole: 250 reports
Mavik and Lasix: 236 reports
Mavik and Crestor: 224 reports

Browse interactions between Mavik and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse interactions between Cutivate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on trandolapril and fluticasone propionate (the active ingredients of Mavik and Cutivate, respectively), and Mavik and Cutivate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Mavik and Cutivate.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

Macrodantin and Novorapid drug interaction - a second ago
Lyrica and Soma Compound drug interaction - 5 seconds ago
Alesse and Haldol drug interaction - 8 seconds ago
Lupron and Evista drug interaction - 10 seconds ago
Lunesta and Cenestin drug interaction - 12 seconds ago
Vitamin B12 and Allergic Rhinitis - 21 seconds ago
Imitrex and Body Temperature Fluctuation - 24 seconds ago
Pantoprazole and Extravasation - 31 seconds ago
Bricanyl and Haematocrit Decreased - 33 seconds ago
Losartan and Fluoxymesterone drug interaction - 34 seconds ago